This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Charles Marwick

JAMA. 1999;281:888.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

BETHESDA, MD—Just 3 months into her new job, Food and Drug Administration (FDA) Commissioner Jane Henney has managed a critical first step in her efforts to deal with the agency's funding problems. The administration's 2000 budget, sent to Congress early in February, proposes $1.35 billion for the FDA. If enacted after review by congressional committees this spring, it will represent an increase of $216 million, nearly 18%, over last year and be the largest increase in resources for the agency in its history.

"This $216 million represents a critical down payment on the FDA's budget," Henney told a gathering of health care professionals here. Recalling her 1992-1994 stint as a deputy under FDA Commissioner David Kessler, she said, "I returned to find the agency's budget lower than when I left."

Except for funds for the so-called high-profile initiatives like food safety and tobacco, funding has been relatively . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?